Swine Flu Update No 17, in Today's News 07.16.09

Swine Flu. Today's Wall Street Journal page A6: "A swine-flu vaccine is proving difficult to manufacture because the viruses used to make the shots aren't yielding a large amount of active ingredient...[it]mean[s] that millions of doses ordered by many governments could arrive later than expected."

What this development really means is that the central planners of the swine-flu scare campaign will have to delay their date for revealing that the flu-bug is more serious than originally thought.

Baxter and Novartis are the two companies that reported the difficulty in manufacturing. The value of their statements doesn't revolve around whether they are true or not.  The main value for the companies is that it gives them cover in case anything goes wrong with the vaccines. If some problem comes up, they can always point back to their statements about the difficulty.

So, not only are these manufacturers going to collect a really big bundle of lucre, but now they have created a sort of insurance policy to safeguard their take.